5-[[2-[(3R)-3α-アミノ-1-ピペリジニル]-3-ビフェニリル]メチレン]チアゾリジン-2,4-ジオン(1204144-28-4)

ChemicalBook Optimization Suppliers
名前: WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd.  Gold
電話番号: 17702719238 17702719238
電子メール: sales@sun-shinechem.com
名前: Shanghai Boyle Chemical Co., Ltd.  
電話番号:
電子メール: sales@boylechem.com
名前: Chembest Research Laboratories Limited  
電話番号: 021-20908456
電子メール: sales@BioChemBest.com
名前: Dalian Meilun Biotech Co., Ltd.  
電話番号: 0411-62910999 13889544652
電子メール: sales@meilune.com
名前: NCE Biomedical Co.,Ltd.  
電話番号: 4000-027-021 |24 +86-13986109188 | +86-15623472865 | +81-08033611988
電子メール:
5-[[2-[(3R)-3α-アミノ-1-ピペリジニル]-3-ビフェニリル]メチレン]チアゾリジン-2,4-ジオン 製品概要
化学名:5-[[2-[(3R)-3α-アミノ-1-ピペリジニル]-3-ビフェニリル]メチレン]チアゾリジン-2,4-ジオン
英語化学名:AZD-1208
别名:AZD 1208;AZD1208;AZD-1208;(5Z)-5-[[2-[(3R)-3-aMino-1-piperidinyl][1,1'-biphenyl]-3-yl]Methylene]-2,4-thiazolidinedione;(5Z)-5-[[2-[(3R)-3-Amino-1-piperidinyl][1,1'-biphenyl]-3-yl]methylene]-2,4-thiazolidinedione AZD1208;(R,Z)-5-((2-(3-aminopiperidin-1-yl)biphenyl-3-yl)methylene)thiazolidine-2,4-dione;(R,Z)-5-((2-(3-aMinopiperidin-1-yl)-[1,1'-biphenyl]-3-yl)Methylene)thiazolidine-2,4-dione;AZD1208 >=95%
CAS番号:1204144-28-4
分子式:C21H21N3O2S
分子量:379.48
EINECS:
カテゴリ情報:Inhibitors;JAK;STAT;JAK/STAT
Mol File:1204144-28-4.mol
5-[[2-[(3R)-3α-アミノ-1-ピペリジニル]-3-ビフェニリル]メチレン]チアゾリジン-2,4-ジオン
5-[[2-[(3R)-3α-アミノ-1-ピペリジニル]-3-ビフェニリル]メチレン]チアゾリジン-2,4-ジオン 物理性質
融点 >220°C (dec.)
比重(密度) 1.307±0.06 g/cm3(Predicted)
貯蔵温度 Hygroscopic, -20°C Freezer, Under inert atmosphere
溶解性DMSO (Slightly)
酸解離定数(Pka)7.39±0.20(Predicted)
外見 Solid
Off-White to Pale Yellow
安全性情報
MSDS Information
5-[[2-[(3R)-3α-アミノ-1-ピペリジニル]-3-ビフェニリル]メチレン]チアゾリジン-2,4-ジオン Usage And Synthesis
使用AZD1208 is a potent, and orally available Pim kinase inhibitor.
生物活性upregulation of pim kinases has been observed in several types of leukemias and lymphomas. pim-1, -2, and -3 promote cell proliferation and survival downstream of cytokine and growth factor signaling pathways. azd1208 is a potent, highly selective, and orally available pim kinase inhibitor.
in vitroazd1208 inhibited the growth of 5 of 14 acute myeloid leukemia (aml) cell lines tested. in molm-16 cells, azd1208 also causes cell cycle arrest and apoptosis, accompanied by a dose-dependent reduction in phosphorylation of bcl-2 antagonist of cell death [1].
in vivoazd1208 inhibits the growth of kg-1a and molm-16 xenograft tumors in vivo with a clear pk/pd relationship. treatment with 10 mg/kg or 30 mg/kg of azd1208 led to an 89% tumor growth inhibition or slight regression, respectively [1].
targetPim1
IC 500.4 nm for pim-1, 5.0 nm for pim-2, and 1.9 nm for pim-3
貯蔵Store at -20°C
参考文献[1] keeton ek, mceachern k, dillman ks, palakurthi s, cao y, grondine mr, kaur s, wang s, chen y, wu a, shen m, gibbons fd, lamb ml, zheng x, stone rm, deangelo dj, platanias lc, dakin la, chen h, lyne pd, huszar d. azd1208, a potent and selective pan-pim kinase inhibitor, demonstrates efficacy in preclinical models of acute myeloid leukemia. blood. 2014;123(6):905-13.
Tags:1204144-28-4